Wearable sensors to monitor everything from step count to heart rate are nearly ubiquitous. But for scenarios such as measuring the onset of frailty in older adults, promptly diagnosing deadly diseases, testing the efficacy of new drugs or tracking the performance of professional athletes, medical-grade devices are needed.
We developed a proof-of-concept connected module to fit inside the rear cap of Bespak by Recipharm’s existing auto-injector.
The final major trend towards a new digital age was the rising adoption of connected health within the global population, who were already using smartphones to track their health and fitness.“That can go up to disease management tracking with new applications and even up to a certain extent, to closed loop systems; very advanced technologies which manage not only the treatment but also the diagnoses, and can adjust the dose needed by the patient,” she said. “So in a nutshell, all these trends fuel into drug delivery devices and have also set the ground for the growing share of which they are taking within the connected space.”
OUI Inc. is a university-launched venture company launched in July 2016 by an ophthalmologist at Keio University School of Medicine with the philosophy of “growing medical care.” We developed the iPhone attachment-type medical device SEC, which enables ophthalmic examinations, from scratch and completed it in about one and a half years.
MHealth is the concept of mobile health care. It’s a collection of consumer technologies that enable consumers to capture their own health data, often without our assistance or ability to interpret it. And presumably, this data can be used to enhance the health of the user.
Founded in 2013, Babyscripts works directly with providers of care, including OB/GYN practices, health systems and midwifery clinics. Expectant mothers are provided with a blood pressure cuff, which they can use at home; if any readings are abnormal, the doctor is immediately alerted. If the patient has diabetes, the company also offers a functionality to monitor blood sugar through a glucometer. There also a Babyscripts app that provides patients with education, all of which is controlled by the doctor.
For this latest analysis, four FDA representatives tested all iPhone 12 and Apple Watch 6 models to see if their magnets might cause implantable pacemakers or implantable cardioverter-defibrillators (ICDs) to inadvertently enter “magnet mode.” All phones and watches were fully charged and then disconnected from charging cables before being evaluated.
Researchers at Nanyang Technological University in Singapore created a flexible battery that is powered by sweat. The device could provide a new way to energize medical wearables, some of which already use sweat to detect or monitor disease. The stretchable device incorporates silver flakes that clump together and generate a small electrical current in the presence of sweat.
Wearable Medical Devices, Biosensors, and Monitoring Patches improve patient recovery with increased monitoring of prescribed activities, vitals and other health events. This data combined with new software and artificial intelligence improves diagnosis accuracy and speed as well as increases the efficiency, convenience, customization and cost management of healthcare. Wearable patches and biosensors commonly include Glucose Monitors, Insulin Pumps, Cardiac Monitor Patches, or Medical Patches like those used for Sleep Monitoring.
“Teaming up with Withings ensures One Drop employer members have continued access to premium devices, making it easier and more enjoyable to track biometric data like weight and blood pressure,” Brian Kemper, SVP of enterprise solutions. “We expect to collect a significant amount of meaningful health information from connected Withings devices, building upon our unparalleled data wealth and powering predictive algorithms to deliver real-time insights that enable people to achieve health outcomes.”
Under European patent law, methods for treatment of the human or animal body by surgery or therapy are excluded from patentability. Diagnostic methods practiced on the human or animal body are also excluded. The rationale behind these exclusions is to avoid the situation where a medical professional is prevented from treating or diagnosing a patient due to the existence of a patent right.
WIM – a wearable heating pad which is a great way for naturally relieving menstrual cramps and help women feel comfortable wherever they go.WIM gives women more control over their life when they’re menstruating, unlike any other technology.
The only thing worse than a Monday morning is having your periods start suddenly on a Monday morning! Dragging yourself to work, while your cramps are at an all-time high and your mood at an all-time low is literally hell on Earth. You can pop in a painkiller, but the effect only lasts for a few hours, and it isn’t my preferred means of relief, to be honest. And a proper heating pad is almost impossible to carry around with you! Hence, Sofia Papenova and Lidia Grits designed WIM, a smart heating pad that you can actually wear!
The pandemic contributed to another 90,000 apps being introduced in 2020 – an average of 250 per day – and this coupled with rising number and functionality of wearable devices “provides evidence of digital health’s accelerating innovation,” according to the IQVIA Institute for Human Data Science’s 2021 trends report.
A great report on Digital Health Trends from IQVIA.
Significant gaps remain in our understanding of Covid-19, and in many ways the coming period is going to be one of trial and error for nations. In particular, the asymptomatic nature of the virus in its early phase means that there is always a risk of unknown transmission. Governments will need effective trigger mechanisms – using novel data sources – and agile and responsive systems that enable them to act quickly if the reproduction number creeps up. Individuals may also want to take on greater responsibility for their health and disease detection, given the near universal failure of countries to price in risk and prepare for a pandemic, despite numerous warnings. With the power to both aggregate data and empower individuals, wearables could form part of a solution.
In April 2021, Fitbit announced a trial to determine whether its smartwatches can accurately detect hypertension. Preliminary research suggests the device can be used to measure blood pressure from the wrist, but the new study will extend those findings to a larger population. The company acknowledges that although there is great interest in monitoring blood pressure using wearables, this method has not yet been properly validated. Wrist measurements have so far failed to prove as accurate as those from a cuff. Fitbit users in the US who are at least 20 years old are participating in the study.
After working to make its continuous glucose monitoring systems compatible with the major players in the diabetes device industry, Dexcom is opening its doors much wider. With an FDA blessing for Dexcom’s new web-based APIs, the company can invite digital health companies to feed its CGM data into their own health apps and devices—potentially expanding the different ways people with diabetes can share and use their blood sugar stats.
Accidental medical errors, specifically related to drug delivery and toxicity-related events, are the third largest cause of death among Americans, according to CNBC. More than 131 million adult Americans are making some sort of prescription medication in the form of an ingestible. Over 11.8 million people worldwide use an injectable device to deliver their medication daily. Now, the two devices that were mentioned, ingestible pills and the syringe needle used to inject medication, were invented in 1500 BCE and 1853 respectively. These forms of pharmacology delivery have not had dramatic changes since their inception into the world of medication. Even when taking into consideration medical safety, the largest changes in the form that these devices take have come from the inversion of the needle following injection and the “controlled-release” of medication from the pill form.
As per the permission granted by the Federal Communications Commission (FCC), Amazon's Radar sensor will operate in the 57-64GHz frequency band. The spectrum had previously been used for facilitating secure communications but since 2001 has been set aside by the FCC for unlicensed wireless communications.
Addressing the need for streamlined power management solutions for energy harvesting hardware, e-peas has unveiled a new family of battery charger devices. While the company’s existing power management ICs (PMICs) offer direct power delivery to the application, as well as the charging of energy storage elements (such as Li-Ion batteries or super-capacitors), the AEM10900, AEM10300 and AEM30300 are fully dedicated to the charging function. This allows them to be employed in situations that need a simpler implementation, where there are space or cost constraints that need to be considered.
Medical Wearables is a fast growing market segment that requires Boyd’s unique expertise in developing smaller, lighter, higher performing solutions for next generation applications. The article highlights how to best utilize these technologies to reduce weight and landed costs, as well as streamline the supply chain for the full spectrum of Medical Devices.
This wearable hybrid device, functioning as both a biofuel cell and a supercapacitor, is demonstrated to deliver high-power pulses and be rapidly self-recharged using enzymatic oxidation of lactate biofuel from human perspiration. This work enabled material-level integration of both functionalities on the same set of electrodes, thus reducing the system complexity and minimizing the device footprint.
The new skin is equipped with artificial sweat ducts that resemble pores in human skin and that have been etched through the material’s ultrathin layers. This ensures that sweat can escape through the electronic skin avoiding damaging and deteriorating the wearable skin.
Medical wearables provide practitioners with a treasure trove of health data that can be used to monitor and treat patients – and they are only getting better
We’re used to the idea of wearable technology measuring everything from our temperature and heart rate, to blood glucose levels and sleep. But what if we moved those devices inside the body? That’s what Swedish startup DSRuptive does, using small glass capsules — the size of a grain of rice. On Wednesday, the company announced the results of the first clinical study showing the effectiveness of injectable implants in monitoring body temperature. The results are a glimpse into a future when implants could be the norm for everything, from health monitoring to payments and identification.
We demonstrated a valuable supplement to traditional PROs by using smartphone-based activity data. This methodology yields a rich data set that has the potential to augment our understanding of patient recovery.